Breastfeeding reduces type 2 diabetes risk by boosting beta cells.

Scientists have developed a tissue-clearing protocol that allows them to peer into entire, transparent human organs.

Insulin-producing cells grown in the lab could offer a functional cure for the disease.

Results from an observational study find that the introduction of a routine vaccine in Australia coincided with a fall in the incidence of the autoimmune condition.

Progenitor cells in the pancreas of humans get developmental cues from proteins in their environment.

The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.

Live-cell imaging reveals the secrets of innervation in the pancreas of zebrafish.

Species with larger pancreatic cells tend to have shorter lives, according to a study.  

Researchers used a trio of transcription factors to transform pancreatic duct cells in vivo into β-like cells that secrete insulin and improve diabetes symptoms.

Pancreatic cells engineered to produce insulin did not immediately provoke an immune response.

A small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.

Mouse organoids reveal that a protein active during embryonic development joins forces with gene enhancers to revert cancer cells to an earlier developmental state.

Scientists have constructed three-dimensional maps depicting the size and location of insulin-producing islet cells in the mouse pancreas.

The diabetic volunteer continued to produce insulin one year after she received a transplant of abdominal islet cells.

Researchers produce functional organs composed of both mouse and rat cells.

Lipids and insulin play important roles in blood sugar regulation, and altered levels of either could kick start metabolic dysfunction.

Scientists grow gastric organs in vitro that can restore insulin production when transplanted into mice.

Researchers craft hormone-producing pancreas cells from human embryonic stem cells, paving the way for a cell therapy to treat diabetes.

In diabetic mice, the cells of the pancreas don’t die, but rather revert to an earlier state incapable of producing the insulin the body needs.